Safety information needs a clear route from receipt to assessment and follow-up. We support partners in organizing pharmacovigilance activities and the exchange of information between responsible teams.
The path of safety information
Pharmacovigilance relies on information reaching the responsible people through a defined process. We discuss information sources, transfer arrangements and responsibilities with the partner.
Reviewing existing safety information processes and needs.
Coordinating information collection and transfer activities.
Aligning documentation and links with the partner’s system.
Connecting related medical and regulatory tasks.
What do we discuss before starting?
The initial discussion covers products, markets, the structure of the partner’s system and the intended service scope. We agree who receives information, who assesses it and how the responsible parties communicate.
This website’s general form is intended for business enquiries. For safety reports about a particular medicine, use the channel specified in its product information. Do not include patient documents in an initial partnership enquiry.
Defined processes and responsibilities
The service scope can cover safety reporting coordination, literature monitoring and local risk communication. Agreements define escalation routes, documentation and responsibilities for the specific product and market.
Collaboration starts with a conversation
Let’s discuss your product’s needs in Lithuania, Latvia and Estonia.
Our market focus is Lithuania, Latvia and Estonia. We shape the work around the priorities of these three Baltic countries and agree the scope for each product with our partner.